Comparative effectiveness of single-stage versus two-stage revision for hip prosthetic joint infection: emulation of the INFORM target trial using electronic health record data - Scorecard - MDSpire
Conexiant’s news site is now MDSpire News. Learn more
Advertisement
Effectiveness Comparison of Single-Stage and Two-Stage Revision Strategies for Hip Prosthetic Joint Infections: Insights from an INFORM Target Trial Emulation Utilizing Electronic Health Records
Clinical Scorecard: Effectiveness Comparison of Single-Stage and Two-Stage Revision Strategies for Hip Prosthetic Joint Infections: Insights from an INFORM Target Trial Emulation Utilizing Electronic Health Records
At a Glance
Category
Detail
Condition
Hip Prosthetic Joint Infection (PJI)
Key Mechanisms
Single-stage revision involves immediate replacement after debridement; two-stage revision involves an interim period with an antibiotic spacer.
Target Population
Adults aged ≥ 18 years with confirmed hip PJI requiring revision surgery.
Care Setting
Tertiary hospitals in China
Key Highlights
Single-stage revision showed superior function at 3 months compared to two-stage revision.
Intraoperative adverse events were lower in single-stage revision (8% vs 27%).
At 18 months, no significant difference in infection markers between single-stage (14%) and two-stage (11%) revisions.
Guideline-Based Recommendations
Diagnosis
Confirm hip PJI prior to revision surgery.
Management
Consider both single-stage and two-stage revision strategies based on patient context.
Monitoring & Follow-up
Assess functional outcomes and infection markers at 3 and 18 months post-revision.
Risks
Be aware of potential for increased intraoperative adverse events with two-stage revision.
Patient & Prescribing Data
Predominantly White European patients undergoing THA for osteoarthritis in the INFORM trial; younger, mainly male patients in China.
Microbiological characteristics and indications for THA differ between populations, which may affect treatment outcomes.
Clinical Best Practices
Utilize electronic health records for retrospective cohort studies.
Follow ethical guidelines and obtain necessary approvals for observational studies.
Related Resources & Content
BMJ, 2022 -- Clinical and cost effectiveness of single stage compared with two stage revision for hip prosthetic joint infection (INFORM): pragmatic, parallel group, open label, randomised controlled trial
Clinical Infectious Diseases, 2023 -- Executive Summary: Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guidelines by the Infectious Diseases Society of America
Springer, 2022 -- Assessing the Risk of Failure in Two-Stage Revision for Periprosthetic Joint Infection Following Cemented Total Hip Arthroplasty
Springer, 2021 -- Success Rates of Repeat Two-Stage Exchange Arthroplasty for Recurrent Periprosthetic Infections in Hip and Knee Joints
Springer, 2024 -- Results of a Cemented Modular Rotational-Hinge Implant Used in Two-Stage Revision for Chronic Periprosthetic Joint Infection of the Knee
Infection — The Role of Antibiotic-Infused Cement Spacers in Reducing Reinfection Risk Following Septic Two-Stage Hip Revision Surgery
Executive Summary: Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guidelines by the Infectious Diseases Society of Americaa | Clinical Infectious Diseases | Oxford Academic
Clinical and cost effectiveness of single stage compared with two stage revision for hip prosthetic joint infection (INFORM): pragmatic, parallel group, open label, randomised controlled trial | The BMJ
Comparative reinfection rate of one-stage versus two-stage revision in the management of periprosthetic joint infection following total hip arthroplasty: a meta-analysis - PMC
Investigators compared intra-articular microbial profiles and predicted metabolic pathways in patients with hip osteoarthritis and nonarthritic controls.